NO940227L - Fremgangsmaate for fremstilling av mellomprodukter for syntese av chirale tiazolidin-2,4-dion-derivater - Google Patents

Fremgangsmaate for fremstilling av mellomprodukter for syntese av chirale tiazolidin-2,4-dion-derivater

Info

Publication number
NO940227L
NO940227L NO940227A NO940227A NO940227L NO 940227 L NO940227 L NO 940227L NO 940227 A NO940227 A NO 940227A NO 940227 A NO940227 A NO 940227A NO 940227 L NO940227 L NO 940227L
Authority
NO
Norway
Prior art keywords
preparation
intermediates
synthesis
dione derivatives
thiazolidine
Prior art date
Application number
NO940227A
Other languages
English (en)
Norwegian (no)
Other versions
NO940227D0 (no
Inventor
George Joseph Quallich
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO940227D0 publication Critical patent/NO940227D0/no
Publication of NO940227L publication Critical patent/NO940227L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO940227A 1991-07-22 1994-01-21 Fremgangsmaate for fremstilling av mellomprodukter for syntese av chirale tiazolidin-2,4-dion-derivater NO940227L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73356491A 1991-07-22 1991-07-22
PCT/US1992/005433 WO1993002060A1 (fr) 1991-07-22 1992-07-01 Procede de preparation d'intermediaires dans la synthese de derives chiraux de thiazolidine-2,4-dione

Publications (2)

Publication Number Publication Date
NO940227D0 NO940227D0 (no) 1994-01-21
NO940227L true NO940227L (no) 1994-01-21

Family

ID=24948157

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940227A NO940227L (no) 1991-07-22 1994-01-21 Fremgangsmaate for fremstilling av mellomprodukter for syntese av chirale tiazolidin-2,4-dion-derivater

Country Status (21)

Country Link
US (1) US5512689A (fr)
EP (1) EP0595868B1 (fr)
JP (1) JP2671962B2 (fr)
AT (1) ATE173728T1 (fr)
AU (1) AU660701B2 (fr)
CA (1) CA2111445C (fr)
DE (1) DE69227689T2 (fr)
DK (1) DK0595868T3 (fr)
ES (1) ES2123562T3 (fr)
FI (1) FI940306A0 (fr)
HU (1) HUT70412A (fr)
IE (1) IE922359A1 (fr)
IL (1) IL102574A (fr)
MX (1) MX9204278A (fr)
MY (1) MY131277A (fr)
NO (1) NO940227L (fr)
NZ (1) NZ243651A (fr)
PT (1) PT100710B (fr)
TW (1) TW199891B (fr)
WO (1) WO1993002060A1 (fr)
ZA (1) ZA925469B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2111446C (fr) * 1991-07-22 1997-12-16 George J. Quallich Intermediaires chiraux servant a l'obtention de thiazoles antidiabetiques
FR2699172B1 (fr) * 1992-12-11 1995-01-20 Adir Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
TW416958B (en) * 1993-05-14 2001-01-01 Pfizer Enantioselective oxazaborolidine catalysts
EA200200311A1 (ru) * 1999-08-31 2002-08-29 Максиа Фармасьютикалз, Инк. Бензилиден-тиазолидиндионы и аналоги и их применение для лечения диабета
AU2002252227A1 (en) 2001-03-07 2002-09-24 Maxia Pharmaceuticals, Inc. Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
JP2004523571A (ja) * 2001-03-08 2004-08-05 マキシア・ファーマシューティカルズ・インコーポレイテッド Ｒｘｒ活性化分子
CA2340824A1 (fr) * 2001-03-14 2002-09-14 Ibm Canada Limited-Ibm Canada Limitee Methode et systeme pour l'analyse du comportement des applications
US20030083357A1 (en) * 2001-08-17 2003-05-01 Magnus Pfahl Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
AU2002352706A1 (en) * 2001-11-15 2003-06-10 Maxia Pharmaceuticals, Inc. N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US7196108B2 (en) * 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US20050014767A1 (en) * 2003-01-29 2005-01-20 Magnus Pfahl Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
JP2006523724A (ja) * 2003-04-18 2006-10-19 インサイト サン ディエゴ インコーポレイテッド 代謝障害、癌および他の疾患の治療のための置換イソクロマン化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943635A (en) * 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
TW222626B (fr) * 1991-07-22 1994-04-21 Pfizer

Also Published As

Publication number Publication date
CA2111445C (fr) 1997-02-18
IL102574A0 (en) 1993-01-14
MX9204278A (es) 1994-03-31
FI940306A (fi) 1994-01-21
AU660701B2 (en) 1995-07-06
ES2123562T3 (es) 1999-01-16
NZ243651A (en) 1994-01-26
PT100710B (pt) 1999-07-30
ATE173728T1 (de) 1998-12-15
JPH07502017A (ja) 1995-03-02
IE922359A1 (en) 1993-01-27
DE69227689T2 (de) 1999-04-22
HUT70412A (en) 1995-10-30
PT100710A (pt) 1993-09-30
DK0595868T3 (da) 1999-08-09
MY131277A (en) 2007-07-31
US5512689A (en) 1996-04-30
JP2671962B2 (ja) 1997-11-05
CA2111445A1 (fr) 1993-02-04
HU9400188D0 (en) 1994-05-30
EP0595868B1 (fr) 1998-11-25
AU2306292A (en) 1993-02-23
WO1993002060A1 (fr) 1993-02-04
FI940306A0 (fi) 1994-01-21
DE69227689D1 (de) 1999-01-07
ZA925469B (en) 1994-01-21
NO940227D0 (no) 1994-01-21
TW199891B (fr) 1993-02-11
IL102574A (en) 1996-07-23
EP0595868A1 (fr) 1994-05-11

Similar Documents

Publication Publication Date Title
NO940227D0 (no) Fremgangsmaate for fremstilling av mellomprodukter for syntese av chirale tiazolidin-2,4-dion-derivater
AR038430A2 (es) Derivados de parahercuamida b
FI102069B (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmist amiseksi
GR3036305T3 (en) Chiral methyl phenyl oxazolidinones
PT87717A (pt) Process for preparing 2,4-thiazolidinedione derivatives
TW334430B (en) Preparation process for benzoyl derivatives and its intermediates
ES2086065T3 (es) Preparacion de tetrahidropiridinas sustituidas.
AU686955B2 (en) Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives
NO20032401D0 (no) Fremgangsmåte ved fremstilling av taksanderivater
NO885100L (no) Anvendelse av 1,3-butandiolacetoacetat som naeringsmiddel,saerlig for parenteral tilfoersel.
FI906084A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 5-(2-metyyli-4,4,4-trifluoributyylikarbamoyyli)indolijohdannaisten valmistamiseksi
HUT63621A (en) Process for producing new oxazolidine derivatives
EP0250755A3 (en) Fluorine derivatives of vitamin d3 and process for producing the same
ATE259800T1 (de) Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
AU651717B2 (en) Process for the production of methyl acetate
FI906324A0 (fi) Anordning och foerfarande foer foerkromning av artiklar.
JPS5620584A (en) Novel oxygenncontaining heterocyclic compound
NO980937D0 (no) Fremgangsmåte for fremstilling av benzyl-substituerte rhodaninderivater
DE3864286D1 (de) Herstellungsverfahren von trifluormethylverbindungen.
FI973206A (fi) Menetelmä välituotteina käyttökelpoisten halogeeniasetamidijohdannaisten valmistamiseksi
AU652099C (en) Alkene intermediates for the production of certain 1,2-dioxetane compounds
PH24971A (en) N2-thiocylcarbazate compounds and derivatives thereof
HU9201664D0 (en) Process for the production of intermedier nizatidine and its derivatives